Hua Xin

Quick links to important sections

Hua Xin

Method of action: Other Nervous System Drugs

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hua Xin

Quick Facts

Property Description
Active Ingredient Flunarizine (as Dihydrochloride salt)
Form Capsules or Tablets (Oral route)
Pharmacological Class Selective Calcium Channel Blocker (Calcium Antagonist)
General Purpose Mitigation of vascular and neurophysiological instability
Origin Synthetic (Diphenylmethylpiperazine derivative)

What is Hua Xin: Definition, Form, and Core Composition

The medication known as Hua Xin is a synthetic prescription drug containing the active ingredient Flunarizine. This compound is chemically defined as a Diphenylmethylpiperazine derivative and is classified as a Calcium Channel Blocker (Calcium Antagonist). Hua Xin is administered via the oral route in solid dosage forms, primarily capsules or tablets, confirming its preparation as a single-entity pharmaceutical product.

Flunarizine’s Place in Pharmacology

Flunarizine is pharmacologically distinguished as a selective Ca^2+ entry blocker, meaning it demonstrates a targeted influence on specific voltage-dependent calcium channels within nerve and vascular cells. This selectivity is a differentiating factor, supporting a focused, sustained stabilizing action on tissues prone to excessive excitability. Flunarizine reduces excessive calcium influx, contributing to vascular dilation and decreased total peripheral resistance. The medicine is characterized by its capacity to promote better blood flow stability and cellular calm.

What is Hua Xin Generally Used For?

The overall utility of the medication lies in its capacity to address underlying physiological imbalances, making it a foundationally important agent. The drug’s mechanism leads to the general benefit of promoting stable cerebral blood flow and reducing inappropriate neuronal excitability. Its long clinical history, exceeding 25 years in some regions, supports its role as a systemic modulator intended to mitigate the fundamental stresses related to abnormal vessel tension and neural hyper-responsiveness.

What side effects are possible with Hua Xin?

Possible Side Effects and Safety Information

The regulatory safety profile of Hua Xin (Flunarizine) is structured around two categories of concern: common metabolic and central nervous system effects, and specific serious neuropsychiatric reactions. Adverse reactions are officially classified by the physiological system affected and their reported frequency.


Frequency and System-Organ Classes

The most frequently documented effects fall into the Very Common (ge 1/10) and Common (ge 1/100 to < 1/10) frequency bands:

  • Very Common: Weight Increased (Weight Gain) and Somnolence (Drowsiness/Sedation).
  • Common: Adverse reactions listed include Depression, Increased Appetite, Insomnia, Constipation, Fatigue, and Menstruation Irregular. These affect the Metabolism and Nutrition, Psychiatric, and Reproductive System organ classes.

Uncommon reactions include Anxiety, Muscle Spasms, and Hyperhidrosis (excessive sweating).


Serious Adverse Reactions and Safety Constraints

The official labeling notes a risk of specific Serious Adverse Reactions, which are often associated with the duration of treatment. These include the development of Extrapyramidal Symptoms (such as Parkinsonism-like movement problems) and the precipitation or worsening of Depression. These risks are particularly noted in association with long-term use.

Use is officially restricted (contraindicated) in individuals with a current depressive illness or a history of recurrent depression, and in patients with pre-existing Extrapyramidal Disorders.

Specific caution is noted for older adults, who may be more susceptible to developing depression and extrapyramidal symptoms. Use is generally not recommended in children under 18 years of age due to limited safety data.

Overdose and Emergency Response

The official regulatory profile for Hua Xin overdosage defines specific clinical manifestations and mandates immediate emergency action. The documented overdose presentations include central nervous system effects such as sedation and agitation, along with the cardiovascular sign of tachycardia (rapid heartbeat). Due to the potential for serious clinical changes, individuals who suspect an acute overdosage must seek immediate medical attention and contact emergency services, as mandated by official regulatory guidance for all overdosage events.

Management of an overdose is strictly limited to supportive care, as the official prescribing information states that no specific antidote is known for Flunarizine. Treatment procedures are consequently focused on stabilization and decontamination. Officially described supportive measures include the use of gastric lavage and charcoal administration, where deemed medically appropriate. The required symptomatic and supportive treatment necessitates hospital monitoring of vital signs and clinical status following the initial emergency response. Official documentation does not provide explicit classifications of overdose severity or population-specific considerations for patients with hepatic or renal impairment.

Therapeutic Uses of Hua Xin

Hua Xin is generally used to offer supportive therapeutic benefit focused on easing the patient's symptomatic burden during acute episodes and periods of heightened distress. Supportive treatment focused on comfort is often prioritized.

The medication is commonly used in situations involving certain distressing symptoms, such as those that create noticeable functional strain or interfere with daily comfort. It is considered relevant across domains involving acute symptom patterns and conditions characterized by periods of heightened symptoms. Clinical scenarios often involve applying Hua Xin when symptoms intensify and short-term symptomatic assistance is needed.

“Hua Xin supports patients during difficult episodes by easing distress and contributing to improved day-to-day comfort.”

It is applied in addressing various categories of recurrent or episodic manifestations, helping manage symptom clusters that may become intense or disruptive.

Quick Fact: Relief for Disruptive Symptoms
Hua Xin provides support that helps ease the overall symptom load and assists with maintaining functional stability during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Hua Xin? — Official Regulatory Information

The eligibility profile for Hua Xin (Flunarizine) is strictly defined by regulatory documents, identifying specific populations for whom use is prohibited or restricted.


Absolute Contraindicated Populations

This medication is contraindicated and must not be used by individuals with a current depressive illness or a history of recurrent depression. Absolute prohibitions also apply to patients with pre-existing symptoms of Parkinson's Disease or other extrapyramidal disorders. Furthermore, use is prohibited in cases of known hypersensitivity to the active ingredient or any excipients, including those with specific hereditary metabolic disorders like galactose intolerance.


Age and Physiological Restrictions

Use is generally reserved for adults aged 18 years and older. The safety and efficacy of the medicine have not been established in children and adolescents younger than 18, meaning its use is not recommended in this age group. For older adults (65 and over), use is permitted only with caution and requires close monitoring for the potential development of extrapyramidal or depressive symptoms. During pregnancy, use is preferable to avoid, and breastfeeding women should not breastfeed while taking the medicine.


Conditional Use

Caution is also required when administering the medicine to patients with compromised liver function (hepatic impairment) due to the drug's metabolic pathway.

What should I know about interactions with other medicines?

The official regulatory profile for Hua Xin (Flunarizine) describes clinically significant interactions across both pharmacokinetic and pharmacodynamic domains. This information is derived from official regulatory documents, such as the Summary of Product Characteristics and Prescribing Information, and details specific constraints for co-administration.


Pharmacokinetic and Exposure-Altering Interactions

Co-administration of Hua Xin with specific enzyme inducers affects its clearance. Carbamazepine and Phenytoin are documented to increase the metabolism of Flunarizine, a process resulting in lower serum concentrations of the drug. Conversely, the serum concentration of Flunarizine is documented to be increased when combined with Abametapir. This requires consideration of altered drug exposure.

Pharmacodynamic and CNS Reinforcement

Hua Xin is noted to carry a risk of enhanced sedative effects when used alongside other central nervous system (CNS) depressants. This applies to medicinal products such as Benzodiazepines, as well as substances like Alcohol. Additionally, combining Hua Xin with beta-blockers or other calcium channel blockers may potentiate hypotensive effects.


Other Documented Interactions

The official profile includes a note regarding Oral Hormonal Contraceptives, stating that their efficacy may be reduced due to the drug’s effect on delayed gastric emptying. Furthermore, the drug's primary hepatic metabolism is a required consideration for interaction potential in patients with hepatic impairment.

Mechanism of Action

How Hua Xin Works

Modulation of Key Signaling Pathways

Hua Xin acts within domains involving receptor- or enzyme-mediated signaling by initiating or suppressing sequences that lead to downstream effects. This mechanism involves the alteration of early molecular steps within the target cell, influencing systemic physiological outcomes by producing altered activity profiles within targeted pathways.


Regulation of Inflammatory Responses

The compound engages mechanisms that regulate specific cellular processes by affecting systems where particular transmitters or mediators are highly active. This action mediates pathway adjustment through the reduction of the effective concentration of specific mediators and the modification of feedback loops in processes characterized by high basal activity.


Influence on Metabolic Homeostasis

Furthermore, Hua Xin influences the regulation of processes driven by distinct signaling patterns, specifically those related to metabolic cascades. Modification of these sequences results in an altered set point for homeostatic control within the affected metabolic pathways, thereby influencing downstream cellular activity without reference to clinical outcomes.

Dosage and Administration Information

Official Administration Guidelines: Hua Xin

The name Hua Xin does not correspond to an approved drug product with verifiable dosage and administration information in the official regulatory documents of health authorities. For any medication to have a standardized usage protocol, the instructions must be derived directly from the approved Prescribing Information or Summary of Product Characteristics issued by a regulatory body.

Given the requirement to only report usage instructions explicitly stated in authoritative regulatory sources, no official administration guidelines for a product named "Hua Xin" can be provided.


Summary of Unavailable Labeled Instructions

Administration Scope Regulatory Status
Route of Administration No official verified data found
Official Dosing Schedule No official verified data found
Preparation Requirements No official verified data found
Age-Group Rules No official verified data found

Regulatory Context

When a product lacks a published, verified label from an authoritative body, a defined usage protocol (including dosing frequency, preparation, and age-specific rules) does not officially exist. For certain categories of products or supplements, authorities often have specific provisions for regulation and registration, but these documents do not contain the specific dosage and administration details required for this section.

Patients should only follow dosing instructions that are supported by the official label text from a regulatory authority to ensure proper use.

Recent Clinical Evidence

Hua Xin: Recent Clinical Evidence

The research describing Hua Xin (Flunarizine) primarily involves studies of its use that was studied for prophylaxis for certain conditions characterized by fluctuating or episodic manifestations, such as migraine and vertigo. The evidence base is a mix of older, foundational trials and more recent systematic reviews that pool the findings of these studies.


Evidence for Use in Episodic Migraine Prophylaxis

The research base for Hua Xin stems from numerous Randomized Controlled Trials (RCTs) and Systematic Reviews that research examined its use in conditions involving periods of heightened symptoms. These studies monitor outcomes related to physical discomfort and changes in headache patterns. Pooled analyses of the data from these studies describe patterns related to a change in monthly migraine frequency measurements when compared to an inactive substance (placebo).

The reported outcomes in comparative studies suggested that the measured change in frequency was in the same range as that seen with certain other established prophylactic medications in the specific trial contexts. Separate, smaller research was studied for its use in children and adolescents, with patterns observed related to changes in headache frequency.


Gaps, Limitations, and Uncertainty

Several limitations are noted in the comprehensive scientific reviews. First, many key studies are older, and their methodology may not meet the high standards of contemporary clinical trial design, leading to the risk of bias being noted in some reviews. Second, comparative evidence is lacking for some of the indications, particularly for vestibular migraine, where certainty remains low due to a reliance on smaller, observational trials.

Finally, the majority of clinical trials designed to assess initial changes are short-term, meaning the long-term effects are not fully established, and there is limited information to fully characterize outcomes from continuous use over extended periods.

Key Studies & References

  1. Prophylactic treatments for vestibular migraine: a systematic review and network meta-analysis of randomized clinical trials (2023)
  2. Flunarizine: a review of its role in migraine prophylaxis (2020)

Frequently Asked Questions (FAQ)

Common questions about Hua Xin (FAQ)

Q: How long does it usually take for Hua Xin to show a noticeable effect?

Official patient guidance notes that this medication does not typically work immediately. It may take several weeks of continuous use for the maximum potential benefit to be observed. Some documents state this period could be approximately eight to twelve weeks.

Q: Is Hua Xin described as a permanent or a temporary treatment?

The duration of therapy with this medication is typically assessed periodically by a healthcare provider. For maintenance treatment, official guidelines may recommend a finite period of use (e.g., six months) followed by a drug-free period. The possibility of re-starting the medication is a decision guided by the return of symptoms.

Q: What happens if a person misses a scheduled dose of Hua Xin?

Regulatory patient guidance describes general procedures regarding a forgotten dose. This guidance often suggests taking the dose as soon as it is remembered, unless the time for the next scheduled dose is near. Official guidance states that a double dose should not be taken at the same time to make up for the missed one.

Q: Is Hua Xin generally considered appropriate for long-term use?

Official prescribing information indicates that the optimal duration of use for this medication is not fully determined. Regulatory guidelines often recommend re-evaluating the necessity of continuing the therapy periodically. Official safety information notes a risk of certain serious side effects linked to the duration of treatment.

Q: Are there any specific foods or beverages that should be avoided while taking Hua Xin?

Official product information states that the medication can generally be taken with or without food. However, avoiding alcohol is advised because co-administration may increase the risk of side effects, such as drowsiness. No specific food avoidance is typically documented in regulatory interaction summaries.

Q: How often do serious side effects from Hua Xin typically occur according to official sources?

Official safety profiles classify non-serious side effects by frequency but list serious reactions like Extrapyramidal Symptoms (movement problems) and Depression separately. The risk of these reactions is specifically noted in association with the duration of treatment. Use is contraindicated for individuals who have a history of these conditions.

Q: Does Hua Xin have any known effect on a person's blood pressure?

The medication is classified pharmacologically as a calcium channel blocker. Official information indicates that this mechanism may lead to the dilation of blood vessels and a decrease in systemic blood pressure.

Q: What are the official warning signs of an allergic or severe reaction to Hua Xin?

Official patient guidance lists warning signs for a severe reaction. These may include symptoms of an allergic reaction (such as rash, swelling of the face, tongue, or throat, or trouble breathing). Other signs noted in safety profiles include stiff muscles, shakiness, movement disorders, or pronounced dizziness.

Q: Does having a pre-existing kidney or liver condition affect eligibility for Hua Xin?

Caution is advised for use in patients who have compromised liver function due to the way the drug is metabolized by the body. Some regulatory sources also advise against its use in cases of partial or total urinary tract obstruction. Kidney function is not specifically listed as a contraindication.

Q: How is Hua Xin generally described in comparison to other similar existing treatments?

Clinical research has examined the medication’s outcomes in reducing monthly migraine frequency measurements. The results were noted to be comparable to those seen with certain other established prophylactic medications in the specific trial contexts. Regulatory documents do not offer claims of superiority for one drug over another.

Q: Does Hua Xin come in different available dosage strengths or forms?

The medication is a single-entity pharmaceutical product. It is commonly available in solid dosage forms, specifically tablets or capsules. Official prescribing information lists available dosage strengths.

Q: Have there been studies on Hua Xin's use in combination with common mental health medications?

Official documents specify a risk of enhanced sedative effects when the drug is used alongside other central nervous system (CNS) depressants, such as certain anti-anxiety medications like benzodiazepines. Furthermore, the drug is officially restricted (contraindicated) for patients with a current depressive illness or a history of recurrent depression.

Q: Does Hua Xin have any known official effect on a person’s ability to drive or operate heavy machinery?

Because the medication may commonly cause side effects such as drowsiness, dizziness, or somnolence (sedation), official warnings advise caution for activities that require alertness. This caution applies to operating machinery or engaging in activities that require a high degree of attention.

Q: What is the recommended storage temperature and shelf life of Hua Xin once the container is opened?

Official regulatory documents require the medication to be stored at room temperature, typically below 30°C. The container should be kept tightly closed and protected from light and moisture to maintain stability. The duration of use once the container has been opened is information not always explicitly specified in the public patient materials.

Q: Is memory loss, confusion, or fogginess a reported side effect of Hua Xin?

Confusion and disorientation have been noted as potential adverse effects in regulatory reports. Additionally, clinical reports on long-term use have described the observation of mild memory loss, apathy, and mood disturbances in some patients.

Q: Does Hua Xin have specific restrictions for people with certain types of heart conditions?

Official safety documents state the drug is officially restricted (contraindicated) in patients with pre-existing conditions such as hypotension (low blood pressure), heart failure, and arrhythmia (irregular heartbeat). Caution is generally advised for use in patients who have existing heart problems.

Q: What are the general expectations if a person suddenly stops taking Hua Xin?

Official usage guidance indicates that the sudden discontinuation of the medication may be inappropriate. If a person stops taking the medicine suddenly, the original symptoms for which the medication was taken may return.

Q: Is Hua Xin described as a cure or primarily as a symptom management medicine?

The drug is typically described in official documents as being used for the prophylaxis, or prevention, of certain conditions characterized by instability. It is generally regarded in a pharmacological context as an agent for symptom management and mitigation, rather than a definitive cure.

Q: Does Hua Xin require any special ongoing monitoring or regular blood testing?

Regular check-ups and ongoing monitoring for potential adverse effects are noted as general safety advice for patients taking this medication. Specific risks noted for monitoring include mood changes, such as depression, or the potential development of movement disorders (extrapyramidal symptoms).

Q: Can Hua Xin interact with common over-the-counter cold and flu medicine?

Official patient warnings advise caution regarding combination with over-the-counter drugs that may slow actions or have a sedative effect. This caution applies to certain cold and flu remedies that can cause drowsiness.

Q: How long does it typically take for Hua Xin to be fully cleared from the body after the last dose?

Pharmacokinetic data, which describes how the body processes the drug, is included in official documents. This data indicates that the elimination half-life of the drug after multiple doses is approximately 18 to 19 days.

How should Hua Xin be stored and disposed of?

Storage Requirements

Official regulatory documents define specific conditions to maintain the stability of Hua Xin (Flunarizine).

Detail Requirement
Temperature Store at room temperature, typically below 30°C. Do not freeze.
Protection Keep in the original container, tightly closed, and protected from light and moisture to prevent degradation.
Child Safety As with all medicines, it is a mandatory regulatory requirement to keep Hua Xin out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Hua Xin must be handled to prevent environmental contamination and misuse.

Authorities typically require that unused medicine be disposed of according to local regulations or via authorized drug take-back programs. The product should generally not be flushed down the toilet or disposed of in regular household trash to comply with environmental protection guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hua Xin found in:

A-Z Index: